Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Cardiovascular Disorders

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The changing epidemiology and clinical features of infective endocarditis: A retrospective study of 196 episodes in a teaching hospital in China

Contributed equally
BMC Cardiovascular DisordersBMC series – open, inclusive and trusted201717:113

https://doi.org/10.1186/s12872-017-0548-8

Received: 28 November 2016

Accepted: 28 April 2017

Published: 8 May 2017

Abstract

Background

Infective endocarditis is an uncommon but life-threatening infectious disease. To our knowledge, current investigations of the characteristics of infective endocarditis in our region are scarce. In this study, we aimed to investigate the changes in the epidemiology and clinical features of infective endocarditis.

Methods

A retrospective analysis of clinical data was performed using 196 infective endocarditis cases diagnosed between June 2004 and December 2012 at The First Affiliated Hospital of China Medical University. A comparative analysis of clinical risk factors was also included.

Results

The mean age of the patient cohort was 43.5 (29.0–55.8) years old. Of the 196 cases studied, 128 cases (65.3%) were left native valve infective endocarditis, 13 cases (6.6%) were left prosthetic valve infective endocarditis, and 47 cases (24%) were right valve infective endocarditis. In addition to natural valve endocarditis, many patients also exhibited various types of cardiopathy: 72 cases (36.7%) had congenital cardiovascular malformations, 37 cases (18.9%) had idiopathic mitral valve prolapse and 31 cases (15.8%) had no significant cardiac disease. The primary clinical manifestations that were observed included 168 cases with fever (85.7%), 131 cases with anemia (66.8%), 114 cases with hematuria (58.2%) and 58 cases with splenomegaly (29.6%). Positive blood cultures were detected in 96 cases (49%); the most commonly detected organism was Streptococcus viridans (41 cases; 42.7%), followed by 18 cases (18.8%) of Staphylococcus aureus and 10 cases (10.4%) of Enterococcus. With respect to risk factors, infection with Staphylococcus aureus or gram-negative bacilli (OR = 18.81, 95%CI = 2.39–148.2), congestive heart failure (OR = 8.854, 95%CI = 1.34–54.7), diabetes (OR = 7.224, 95%CI = 1.17–44.7) and age ≥ 60 years (OR = 6.861, 95%CI = 0.94–50.1) were major prognostic risk factors.

Conclusion

Infective endocarditis is more common than previously believed, but there are regional differences with respect to the epidemiological and clinical characteristics of infective endocarditis, and its etiology is diverse and complicated. Our study of the clinically diagnosed cases of infective endocarditis verified the regional characteristics of infective endocarditis using a straightforward retrospective analysis. The geographic variations we observed in the study will be of important value to clinical diagnosis in our region.

Keywords

Infective endocarditisClinical characteristicsRisk factors

Background

Infective endocarditis (IE) is a relatively uncommon disease that develops on the endothelial surface of the heart. The diagnosis is traditionally based on the modified Duke criteria and rests primarily on clinical features and to a lesser extent on laboratory findings, microbiological assessment and cardiovascular imaging. If IE is not treated correctly, mortality rates are high. With the development of medical technology and pharmacotherapy, the clinical characteristics of IE have changed considerably in recent years, and the epidemiology clearly demonstrates geographical differences. To further understand the epidemiology, etiology and prognosis of IE in our region, we performed a retrospective analysis of clinical data from our hospital for the past eight years.

Methods

Study sample

A retrospective analysis was performed of clinical data collected from 196 cases clinically or pathologically diagnosed as IE at The First Affiliated Hospital of China Medical University from June 2004 to December 2012. The data in the retrospective analysis included general information, basic heart disease, clinical manifestations, complications and pathogenic microorganisms of IE in our hospital.

Definition and classification of IE

IE was defined according to the modified Duke criteria [1], subject to the following two conditions: (1) confirmed by pathology, vegetation, or intracardiac abscess memory emboli with bacteria or endocardial vegetations; and (2) clinical diagnosis: meet two major criteria, one major criterion plus three minor criteria, or five minor criteria. The major clinical diagnostic criteria of IE were as follows: (1) two positive blood cultures for the same pathogen; and (2) echocardiography demonstrating endocardial involvement. Minor criteria included the following: (1) risk factors; (2) fever ≥38 °C; (3) vascular phenomena; (4) immune phenomena; and (5) positive blood cultures that do not satisfy major criterion or serological diagnosis as an IE bacterial infection. The 2009 European Society of Cardiology (ESC) issued the “Infective Endocarditis Guide” [1], which suggests the new classification method. In accordance with the infection site and whether biological or artificial materials are involved, IE is divided into four categories: left side autologous valve IE, left prosthetic valve IE, right IE, device-related IE (the latter including IE with a pacemaker or Implantable Cardiac Defibrillator (ICD) and with or without associated valvular involvement).

Statistical methods

All data were analyzed using the SPSS 16.0 software. Univariate predictors of in-hospital death or embolic events were included in the multivariate logistic regression analyses. A p value less than 0.05 was considered statistically significant.

Results

Clinical manifestation and complications

In total, the study included 128 (65.3%) patients with left native valve infective endocarditis (NVE), 13 cases (6.6%) of patients with left prosthetic valve endocarditis (PVE), 47 patients (24%) with right heart infective endocarditis (RHIE) and 8 patients (4.1%) with device-related endocarditis. Among the 196 IE patients, the mean age was 43.5 (29.0–55.8) years old; 136 patients (69.4%) were male. The most common symptom in this group of IE patients was fever (168 cases; 85.7%), followed by anemia (131 cases; 66.8%), heart murmur (119 cases; 60.7%), hematuria (114 cases; 58.2%), splenomegaly (58 cases; 29.6%), skin and mucous membrane petechiae or ecchymoses (7 cases; 3.6%), Osler nodes (8 cases; 4.08%) and Janeway lesions (3 cases; 1.53%). A total of 40 cases (20.4%) were complicated by congestive heart failure, and renal insufficiency was present in 24 cases (12.2%).

The most common fundamental cause of IE was congenital cardiovascular malformations (72 cases; 36.7%), followed by idiopathic bicuspid mitral valve prolapse (37 cases; 18.9%) and rheumatic heart disease (19 cases; 9.7%). Among the 72 cases with congenital cardiovascular malformations, ventricular septal defect (VSD) and bicuspid aortic valve were the most common types, and atrial septal defect and patent ductus arteriosus (PDA) were rare. There were 16 cases (8.2%) each involving valvular degeneration, valve replacement surgery and diabetes. There was no significant cardiac disease in 31 cases (15.8%).

Laboratory tests and etiology

Among these patients, 89 cases (64.5%) exhibited increased erythrocyte sedimentation rate (ESR), 109 cases (70.8%) exhibited increased C-reactive protein (CRP) and 27 cases (17.5%) were positive for rheumatoid factor (RF). There were 96 cases (49.0%) of positive blood cultures. In these 96 cases, 73 cases were positive for Gram-positive cocci, of which 51 cases were Streptococcus (41 cases were Streptococcus viridans, 6 cases were D hemolytic streptococcus, 2 cases were oral Streptococci, 2 cases were Streptococcus mitis), 18 cases were Staphylococcus aureus and 2 cases were Staphylococcus lugdunensis and Micrococcus, respectively. Gram-negative bacilli were detected in 11 cases (Loffi Acinetobacter, Salmonella choleraesuis and Acinetobacter baumannii, for 2 cases; brucellosis, Serratia marcescens, Salmonella typhi, Stenotrophomonas narrow food Aeromonas, and Pseudomonas aeruginosa, each type for 1 case). Ten cases were positive for Enterococci, and 2 cases were positive with fungi. Six cases involved mixed infections.

Risk factors

Using a logistic regression analysis, we determined that age ≥ 60 years (OR = 6.861, 0.94–50.1), congestive heart failure (OR = 8.854, 1.34–54.7), diabetes (OR = 7.224, 1.17–44.7), and the presence of Staphylococcus aureus or gram-negative bacilli (OR = 18.81, 2.39–148.2) were the major risk factors related to death (Table 1).
Table 1

Death risk factor analysis in IE patients

Index

OR (95%CI)

P

 Age ≥ 60(years)

6.861 (0.94–50.1)

<0.05

 Duration ≥1 month

0.452 (0.05–3.93)

0.472

 Congestive heart failure

8.854 (1.34–54.7)

<0.05

 Renal insufficiency

1.350 (0.09–18.8)

0.823

 Diabetes

7.224 (1.17–44.7)

<0.05

 PVE

1.651 (0.17–16.3)

0.667

Staphylococcus aureus or negative bacilli

18.813 (2.39–148.2)

<0.05

 Cardiac conduction abnormalities

2.032 (0.36–11.5)

0.422

Discussion

IE is the infection of heart valves or the ventricular endocardium caused by bacteria, fungi and other microorganisms, such as viruses, rickettsia, chlamydia, and spirochetes. With the continuous change in the epidemiological characteristics of IE, a new set of guidelines for the management of IE was published by the Annual Congress of the European Society of Cardiology (ESC) in 2009 [1], which emphasized the diversity of clinical manifestations and risk factors (such as prosthetic valves, degenerative heart valve disease, and intravenous drug abuse) in IE. Some new additions to the guidelines are worth considering, including regional differences. Therefore, to better understand the regional characteristics of IE and to provide data to support the update of the management guidelines for IE in China, we considered it is necessary to perform a systematic study of the overall characteristics of IE in our hospital. Because our hospital is a first-class level three comprehensive teaching hospital, our data are representative of large domestic hospitals. We collected clinical data on patients with IE from the previous eight years. To our knowledge, this is the first retrospective study on IE performed in our hospital over eight years.

Among the 196 cases, there were 128 cases of NVE, accounting for approximately 65.3% of all cases. In terms of fundamental causes, the incidence of congenital cardiovascular malformations (72 cases; 36.7%) and idiopathic bicuspid mitral valve prolapse were the primary diseases, followed by no heart disease; rheumatic heart disease represented the fourth-most common underlying cause. The ranking of these causes was significantly different from that in other hospital [2]. In recent years, the rate of idiopathic mitral valve prolapse in IE has increased. A foreign study [1] reported that patients with idiopathic mitral valve prolapse are at four to eight times higher risk for IE than those with normal valves.

For the clinical manifestation, the mean age of the 196 patients was 43.5 (29.0–55.8) years old, which is younger than that in previous reports [3, 4]. Due to valvular degeneration, the elderly are more susceptible to IE. Thus, the middle-aged and elderly patients who may be considered the susceptible population should receive greater attention in our region. Fever, anemia, hematuria, heart murmur, splenomegaly, elevated inflammatory markers and a variety of peripheral vascular emboli were the primary clinical manifestations noted in the present study. Research from Polewczyk A (414 cases) [5] indicated that fever, chills and pneumonia were most likely to occur in outpatients, and the proportion of RHIE reported was significantly higher than that recorded in our hospital. Osler nodes and Janeway lesions have been relatively rare in recent years. Although anemia, splenomegaly, hematuria, peripheral vascular emboli and other indicators were not included in the diagnostic criteria for IE, the association between these symptoms and IE has been growing in recent years. In addition to fever, many complications may be considered early symptoms of IE, including heart failure, myocardial infarction, arthritis, lung infections, urinary tract infections, and cerebral emboli. These can be accompanied by other symptoms, such as palpitations, shortness of breath, lower extremity edema, joint pain, cough, sputum production, headache and numbness. Therefore, patients who exhibit an unexplained fever for more than a week in the presence of the above symptoms may be suffering from IE. Research from Spain and [6] and Jerusalem [7] revealed that more than one third of IE cases are associated with medical care, which may be related to economic development.

With respect to the etiology of IE, the proportion of IE patients who are not predisposed to heart disease and valvular degeneration is higher in western countries than in China. In this study, 49% of patients had a positive blood culture, which was significantly lower than that found by similar research by Kanafaniand [8]. This difference is primarily because patients received empiric antibiotic therapy prior to admission. Furthermore, under special culture conditions, some pathogens can be missed. In this study, the most common types of pathogen identified in IE patients in our hospital were Streptococcus viridans, Staphylococcus aureus, Enterococcus and Gram-negative bacilli. Although the level of Streptococcus viridans infections has declined in recent years, this pathogen remains the dominant species in our hospital. This prevalence varies considerably between domestic regions and other countries. Other results [9] from overseas indicated that Staphylococcus, especially Staphylococcus epidermidis and Staphylococcus aureus, is the main pathogen. There are regional differences in the types and distribution of pathogens. Medical care, cardiac interventional therapy, hemodialysis and intravenous drug abuse in foreign IE patients is also correlated with pathogen types [10]. Therefore, when there is a lack of clinical etiological data, an understanding of the changes in the etiology and clinical features of common pathogens may help to provide early and reasonable antimicrobial treatment for IE patients and may avoid or reduce adverse complications. Our analysis revealed that the proportion of Streptococcus viridans endocarditis in our hospital was higher compared with the other groups, yet that proportion of Staphylococcus aureus endocarditis was dominant in other countries [11]. This difference may be due to adhesion molecules from Streptococcus viridans and Staphylococcus aureus that are associated with the valvular surface or to the presence of surface adhesion factors conducive to bacterial colonization.

To further explore the impact of the major death factors, the following information was included in the analysis model: age ≥ 60 years, hospitalization ≥1 month, congestive heart failure, renal insufficiency, diabetes mellitus, new cardiac conduction abnormalities, Staphylococcus aureus or Gram-negative bacilli infections. Our results indicated that age ≥ 60 years (OR = 6.861, 0.94–50.1), congestive heart failure (OR = 8.854, 1.34–54.7), diabetes (OR = 7.224, 1.17–44.7), and Staphylococcus aureus or negative tuberculosis infection (OR = 18.81, 2.39–148.2) were major risk factors for the prognosis of IE patients. Our results exhibited some differences from other studies [4, 12, 13], in which Staphylococcus aureus infections, heart failure and PVE were considered major risk factors that could result in emergency surgery or death. Streptococcus and Staphylococcus were the main pathogens, whereas Staphylococcus epidermidis, coagulase-negative staphylococci and HACKE genus (including Haemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens and Kingella species) were detected less often compared to other countries [14]. The positive rate of blood culture was lower than that reported in other countries, which may be due to special culture techniques or previous antibiotic use. Thus, although the detection rate of staphylococcus is not high, its impact on patient survival cannot be ignored. Therefore, to raise the positive detection rate of pathogenic bacteria, blood culture, serology and molecular biology technology development (such as Polymerase Chain Reaction, PCR) need to be improved, as do correct collection methods and continuous inspections. Comprehensive clinical interventions may prevent the further deterioration of the heart, heart failure and heart function, which requires the cooperation of multiple subjects to improve the prognosis of IE.

Conclusions

Our report details a large, retrospective study summarizing the epidemiology and clinical characteristics of IE of our region in China. This study is useful for the identification of clinical trends and the predictable distribution of prognostic factors. Furthermore, the death risk factor analysis underline the significance of age ≥ 60 years, congestive heart failure, diabetes, and Staphylococcus aureus or negative tuberculosis infection in IE patients.

Abbreviations

CRP: 

C-Reactive protein

ESC: 

European Society of Cardiology

ESR: 

Erythrocyte sedimentation rate

HACKE: 

Including Haemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens and Kingella species

ICD: 

Implantable Cardiac Defibrillator

IE: 

Infective endocarditis

NVE: 

Native valve infective endocarditis

PCR: 

Polymerase Chain Reaction

PDA: 

Patent ductus arteriosus

PVE: 

Prosthetic valve endocarditis

RF: 

Rheumatoid factor

RHIE: 

Right heart infective endocarditis

VSD: 

Ventricular septal defect

Declarations

Acknowledgements

We are grateful for the support of all the laboratory staff.

Funding

This study was financially supported by the research grant (Project No. 2013021091) from the Liaoning Province Natural Science Foundation.

Availability of data and material

The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.

Authors’ contributions

WZ, QZ and JPZ designed the study and drafted the manuscript, and WZ was a major contributor in writing the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable. Because the study involved only secondary analysis of data available (no individual details, images or videos) in the public domain, and we guarantee that all patient data would be treated anonymously and that clinical data would only be used for research purposes.

Ethics approval and consent to participate

Not applicable. The study was a retrospective analysis of clinical data. Because the study involved only secondary analysis of data available (no individual details, images or videos, et al.) in the public domain, it was exempt from ethics review of The First Affiliated Hospital of China Medical University’s Ethics Committee.

Grant support

Liaoning Province Natural Science Foundation (Project No. 2013021091).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Nosocomial Infection Control, The First Affiliated Hospital of China Medical University
(2)
Department of Infectious Diseases, The First Affiliated Hospital of China Medical University

References

  1. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009; 30:2369–413.Google Scholar
  2. Math RS, Sharma G, Kothari SS, Kalaivani M, Saxena A, Kumar AS, et al. Prospective study of infective endocarditis from a developing country. Am Heart J. 2011;162:633–8.View ArticlePubMedGoogle Scholar
  3. Bor DH, Woolhandler S, Nardin R, Brusch J, Himmelstein DU. Infective endocarditis in the U.S., 1998-2009: a nationwide study. PLoS One. 2013;8:e60033.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on Endocarditis-prospective cohort study. Arch Intern Med. 2009;169:463–73.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Polewczyk A, Janion M, Podlaski R, Kutarski A. Clinical manifestations of lead-dependent infective endocarditis: analysis of 414 cases. Eur J Clin Microbiol Infect Dis. 2014;33:1601–8.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Fernández-Hidalgo N, Tornos MP. Epidemiology of infective endocarditis in Spain in the last 20 years. Rev Esp Cardiol (Engl Ed). 2013;66:728–33.View ArticleGoogle Scholar
  7. Korem M, Israel S, Gilon D, Cahan A, Moses AE, Block C, et al. Epidemiology of infective endocarditis in a tertiary-center in Jerusalem: a 3-year prospective survey. Eur J Intern Med. 2014;25:550–5.View ArticlePubMedGoogle Scholar
  8. Kanafani ZA, Mahfouz TH, Kanj SS. Infective endocarditis at a tertiary care centre in Lebanon: predominance of streptococcal infection. J Inf Secur. 2002;45:152–9.Google Scholar
  9. Lee MR, Chang SA, Choi SH, Lee GY, Kim EK, Peck KR, et al. Clinical features of right-sided infective endocarditis occurring in non-drug users. J Korean Med Sci. 2014;29:776–81.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Borde JP, Sitaru G, Kopp WH, Ruhparwar A, Ehlermann P, Lasitschka F, et al. Heart transplantation as salvage therapy for progressive prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis (MRSE). J Cardiothorac Surg. 2016;11:100.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Cancan Gursul N, Vardar I, Demirdal T, Gursul E, Ural S, Yesil M. Clinical and microbiological findings of infective endocarditis. J Infect Dev Ctries. 2016;10:478–87.View ArticlePubMedGoogle Scholar
  12. Castillo JC, Anguita MP, Ruiz M, Pena L, Santisteban M, Puentes M, et al. Changing epidemiology of native valve infective endocarditis. Rev Esp Cardiol. 2011;64:594–8.View ArticlePubMedGoogle Scholar
  13. Lopez J, Fernandez-Hidalgo N, Revilla A, Vilacosta I, Tornos P, Almirante B, et al. Internal and external validation of a model to predict adverse outcomes in patients with left-sided infective endocarditis. Heart. 2011;97:1138–42.View ArticlePubMedGoogle Scholar
  14. Chambers ST, Murdoch D, Morris A, Holland D, Pappas P, Almela M, et al. HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort. PLoS One. 2013;8:e63181.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement